Merck & Co.'s antibiotic for hospital-acquired pneumonia has been fast-tracked by the U.S. Federal Drug Administration, the company said Thursday.
from WSJ.com: US Business http://ift.tt/WgVEGZ
via IFTTT
from WSJ.com: US Business http://ift.tt/WgVEGZ
via IFTTT
No comments:
Post a Comment